Telemedicine management of systemic therapy with isotretinoin of patients with moderate-to-severe acne during the COVID-19 pandemic: A longitudinal prospective feasibility study.

Moreno-Ramírez, DavidDuarte-Ferreras, Miguel AOjeda-Vila, TeresaGarcía-Morales, IreneConejo-Mir, Maria DFernández-Orland, AlmudenaSánchez-Del-Campo, Ana IEiris, NoemíCarrizosa, Ana MRuiz-de-Casas, Andrésde-la-Torre, Jose MHerrerías-Esteban, Juan MFerrándiz, Lara2023-05-032023-05-032022-03-07http://hdl.handle.net/10668/22280enacnegeneral dermatologyisotretinointeledermatologytelemedicineAcne VulgarisCOVID-19Dermatologic AgentsFeasibility StudiesHumansIsotretinoinPandemicsProspective StudiesTelemedicineTelemedicine management of systemic therapy with isotretinoin of patients with moderate-to-severe acne during the COVID-19 pandemic: A longitudinal prospective feasibility study.research article35271937open access10.1016/j.jaad.2022.03.0041097-6787PMC8901237http://www.jaad.org/article/S0190962222003796/pdfhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901237/pdf